SGLT2 inhibitors: cardiorenal metabolic drugs for the ages

J Clin Invest. 2024 Mar 1;134(5):e177625. doi: 10.1172/JCI177625.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Humans
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents